Who owns Myokardia?

Tip: Access positions for across all investors

Analyze quarterly positions in Myokardia with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Myokardia stock

Who bought or sold Myokardia this quarter?

There are no current stakeholders of Myokardia.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Myokardia?

Fund or Company Name Date Sold Shares Held Valued At
FMR Sep 2020 8.0M $1.1B
T. Rowe Price Associates Sep 2020 5.5M $747M
Vanguard Group Sep 2020 4.4M $602M
BlackRock Sep 2020 4.2M $578M
Baker Bros. Advisors Sep 2020 3.0M $410M
Wellington Management Company Sep 2020 2.3M $317M
venBio Select Advisor Sep 2020 1.9M $257M
Perceptive Advisors Sep 2020 1.4M $190M
Invesco Sep 2020 1.3M $176M
Farallon Capital Management Sep 2020 1.2M $167M
Bellevue Group Sep 2020 1.1M $154M
State Street Corporation Sep 2020 1.1M $146M
Rtw Investments Sep 2020 937k $128M
Casdin Capital Sep 2020 870k $119M
Geode Capital Management Sep 2020 774k $106M
D. E. Shaw & Co Sep 2020 754k $103M
Henderson Group Sep 2020 724k $99M
Deerfield Management Company Sep 2020 704k $96M
Hillhouse Capital Advisors Sep 2020 691k $94M
Pictet Asset Management Sep 2020 647k $88M
Northern Trust Sep 2020 639k $87M
Eventide Asset Management Sep 2020 621k $85M
Driehaus Capital Management Sep 2020 518k $71M
Ameriprise Financial Sep 2020 512k $70M
Credit Suisse Sep 2020 503k $69M
Macquarie Group Sep 2020 476k $65M
Charles Schwab Investment Management Sep 2020 453k $62M
Wells Fargo & Company Sep 2020 450k $61M
Cormorant Asset Management Sep 2020 450k $61M
Jpmorgan Chase & Co Sep 2020 426k $57M